What diseases is lamivudine tablets used to treat?

Feb 28, 2021 Source: Cainiu Health
Dr. Zhang Jian
Introduction
What conditions is lamivudine tablets used to treat? Lamivudine is a nucleoside antiviral agent commonly used to treat chronic viral hepatitis B and liver cirrhosis, particularly in patients with elevated hepatic enzyme levels and active viral replication. Although lamivudine rapidly and effectively reduces serum HBV-DNA levels, disease relapse is common after discontinuation, potentially leading to worsening of hepatitis.

Lamivudine tablets are a Western medicine formulation. These tablets are orange-yellow film-coated tablets; once the film coating is removed, the tablet core appears white. So, what conditions does lamivudine treat? Below is an explanation.

480-1.jpg

What diseases does lamivudine treat?

Lamivudine is a nucleoside antiviral agent commonly used to treat chronic viral hepatitis B and liver cirrhosis, particularly in patients with elevated hepatic enzymes and active viral replication. Lamivudine can rapidly and effectively reduce serum HBV-DNA levels; however, disease relapse rates are high after discontinuation, potentially worsening hepatitis. Therefore, patients must strictly follow their physician’s instructions for treatment—self-initiation or self-discontinuation of therapy is strictly prohibited—and undergo regular monitoring of liver function during treatment. Moreover, as lamivudine is an older antiviral agent, long-term use may lead to viral mutations conferring drug resistance, thereby complicating subsequent antiviral therapy selection. Consequently, lamivudine is no longer recommended as a first-line antiviral treatment for hepatitis B and is not considered a preferred agent. Current guidelines recommend more potent, low-resistance antiviral agents such as entecavir, tenofovir disoproxil fumarate (TDF), or tenofovir alafenamide (TAF) for hepatitis B treatment.

Doctor2.jpg

Additional Information: Important Considerations for Lamivudine Tablets

1. Some patients may experience adverse reactions after taking this medication, such as upper respiratory tract infection-like symptoms. A minority of patients may develop abdominal pain or diarrhea; however, these symptoms are typically mild and often resolve spontaneously.

2. Patients allergic to any component of this product must not use lamivudine. Pregnant women within the first trimester should avoid lamivudine therapy. Should any discomfort arise, patients should promptly consult their attending physician for appropriate management adjustments.

Doctor.jpg

The above provides an overview of the indications for lamivudine tablets. We hope this information is helpful to you.